Johnson & Johnson (NYSE:JNJ) is included among the 12 Most Profitable Dividend Stocks to Buy in 2026. Guggenheim Lifts Johnson & Johnson (JNJ) Outlook After Solid Q4 and 2026 Guide   On January 23, Guggenheim analyst Vamil Divan raised his price target on Johnson & Johnson (NYSE:JNJ) to $240 from$227. The firm reiterated a Buy rating. The move followed what he described as “solid” fourth-quarter results, along with initial 2026 guidance that came in slightly ahead of sell-side expectations. After the ...